Igf2-H19, an imprinted tandem gene, is an important regulator of embryonic development, a guardian of proliferation of adult pluripotent stem cells, a regulator of longevity, and a 'passkey' to cancerogenesis

Folia Histochemica et Cytobiologica

Volumn 50, Issue 2, 2012, Pages 171-179

  Ratajczak, Mariusz Z ^a,b  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Cancerogenesis; H19; Igf2; Imprinting; Longevity; References; VSELS

Indexed keywords

RNA H19; SOMATOMEDIN B;

AGING; CARCINOGENESIS; CELL PROLIFERATION; EMBRYO DEVELOPMENT; EPIGENETICS; FUSION GENE; GENE EXPRESSION; GENE FUNCTION; GENE LOCUS; GENOME IMPRINTING; HUMAN; INSULIN LIKE GROWTH FACTOR 2 RNA H19 GENE; LONGEVITY; MOLECULAR IMPRINTING; NONHUMAN; PLURIPOTENT STEM CELL; PRIMORDIAL GERM CELL; REVIEW; TISSUE REGENERATION;

EID: 84863860758     PISSN: 02398508     EISSN: 18975631     Source Type: Journal    
DOI: 10.5603/FHC.2012.0026     Document Type: Review

References (40)

1. Reik W, Walter J. Genomic imprinting: parental influence on the genome. Nat Rev Genet. 2001;2:21-32.
2. Pannetier ML, Feil R. Epigenetic stability of embryonic stem cells and developmental potential. Trends in Biotechnology. 2007;25:556-562.
3. Delaval K, Feil R. Epigenetic regulation of mammalian genomic imprinting. Curr Opin Genet Dev. 2004;14:188-195.
4. Bartolomei MS, Ferguson-Smith AC. Mammalian genomic imprinting. Cold Spring Harbor Perspect Biol. 2011;3:a002592
5. Pant V, Mariano P, Kanduri C et al. The nucleotides responsible for the direct physical contact between the chromatin insulator protein CTCF and the H19 imprinting control region manifest parent of origin-specific long-distance insulation and methylation-free domains. Genes Dev. 2003;17:586-590.
6. Matsui Y, Zsebo K, Hogan BLM. Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture. Cell. 1992;70:841-847.
7. Yamazaki Y, Mann MR, Lee SS et al. Reprogramming of primordial germ cells begins before migration into the genital ridge, making these cells inadequate donors for reproductive cloning. Proc Natl Acad Sci USA. 2003;100:12207-12212.
8. Hajkova P, Erhardt S, Lane N et al. Epigenetic reprogramming in mouse primordial germ cells. Mech Dev. 2002;117:15-23.
9. Shovlin TC, Durcova-Hills G, Surani A et al. Heterogeneity in imprinted methylation patterns of pluripotent embryonic germ cells derived from pre-migratory mouse germ cells. Dev Biol. 2008;313:674-681.
10. Durcova-Hills G, Tang F, Doody G et al. Reprogramming Primordial Germ Cells into Pluripotent Stem Cells. PLoS ONE. 2008;3:e3531.
11. Lefebvre L, Viville S, Barton SC et al. Abnormal maternal behaviour and growth retardation associated with loss of the imprinted gene Mest. Nat Genet. 1998;20:163-169.
12. Shin DM, Zuba-Surma EK, Wu W et al. Novel epigenetic mechanisms that control pluripotency and quiescence of adult bone marrow-derived Oct-4+ very small embryonic like stem cells. Leukemia. 2009;23:2042-2051.
13. Shin DM, Liu R, Klich I et al. Molecular signature of adul bone marrow-purified very small embryonic-like stem cells supports their developmental epiblast/germ line origin. Leukemia. 2010;24:1450-1461.
14. Fu VX, Schwarze SR, Kenowski ML et al. A loss of insulinlike growth factor-2 imprinting is modulated by CCCTC-binding factor down-regulation at senescence in human epithelial cells. J Biol Chem. 2004;279:52218-52226.
15. Gabory A, Jammes H, Dandolo L. The H19 locus: role of an imprinted non-coding RNA in growth and development. Bioessays. 2010;32:473-480.
16. Yoon B, Herman H, Hu B et al. Rasgrf1 Imprinting Is Regulated by a CTCF-Dependent Methylation-Sensitive Enhancer Blocker. Mol Cell Biol. 2005;25:11184-11190.
17. Ratajczak MZ, Kucia M, Liu R et al. RasGrf1: genomic imprinting, VSELs, and aging. Aging. 2011;3:692-697.
18. Choufani S, Shuman C, Weksberg R. Beckwith-Wiedemann syndrome. Am J Med Genet C Semin Med Genet. 2010; 154C:343-354.
19. Eggenschwiler J, Ludwig T, Fisher P et al. Mouse mutant embryos overexpressing IGF-II exhibit phenotypic features of the Beckwith-Wiedemann and Simpson-Golabi-Behmel syndromes. Genes Dev. 1997;11:3128-3142.
20. Kono T, Obata Y, Wu Q et al. Birth of parthenogenetic mice that can develop to adulthood. Nature. 2004;428:860-864.
21. Kucia M, Reca R, Campbell FR et al. A population of very small embryonic-like (VSEL) CXCR4+SSEA-1+Oct-4+ stem cells identified in adult bone marrow. Leukemia. 2006;20:857-869.
22. Zuba-Surma EK, Kucia M, Ratajczak J et al. "Small stem cells" in adult tissues: Very Small Embryonic-like Stem Cells (VSELs) stand up! Cytometry. 2009;75A:4-13.
23. Wojakowski W, Tendera M, Kucia M et al. Mobilization of Bone Marrow-Derived Oct-4+SSEA-4+ Very Small Embryonic- Like Stem Cells in Patients with Acute Myocardial Infarction. J Am Coll Cardiol. 2009;53:1-9.
24. Paczkowska E, Kucia M, Koziarska D et al. Clinical evidence that very small embryonic-like (VSEL) stem cells are mobilized into peripheral blood in patients after stroke. Stroke. 2009;40:1237-1244.
25. Ratajczak MZ, Shin DM, Ratajczak J et al. A novel insight into aging: are there pluripotent very small embryonic- like stem cells (VSELs) in adult tissues overtime depleted in an IGF-1-dependent manner? Aging (Albany NY). 2010;2:875-883.
26. Ratajczak J, Shin DM, Wan W et al. Higher number of stem cells in bone marrow of circulating Igf-1 level low Laron dwarf mice - novel view on Igf-1, stem cells and aging. Leukemia. 2011;25:729-733.
27. Kucia M, Shin DM, Liu R et al. Reduced number of VSELs in bone marrow of Growth Hormone transgenic mice indicates that chronically elevated Igf-1 level accelerates age-dependent exhaustion of pluripotent stem cell pool - novel view on aging. Leukemia. 2011;25:1370-1374.
28. Kucia M, Masternak M, Liu R et al. The negative effect of prolonged somatotrophic/insulin signaling on an adult bone marrow-residing population of pluripotent very small embryonic- like stem cells (VSELs). Age. 2012 (doi: 10.1007/s11357- -011-9364-8).
29. Steger RW, Bartke A, Cecim M. Premature ageing in transgenic mice expressing different growth hormone genes. J Reprod Fertil Suppl. 1993;46:61-75.
30. Kucia M, Ratajczak J, Ratajczak MZ. Are bone marrow stem cells plastic or heterogenous - that is a question. Exp. Hematol. 2005;33:613-623.
31. Bartke A, Brown-Borg H. Life extension in the dwarf mouse. Curr Top Dev Biol. 2004;63:189-225.
32. Bartke A, Chandrashekar V, Bailey B et al. Consequences of growth hormone (GH) overexpression and GH resistance. Neuropeptides. 2002;36:201-208.
33. Ratajczak MZ, Dong-Myung Shin, Kucia M. Very small embryonic- like stem cells (VSELs): a missing link to support the germ line hypothesis of cancer development? Am J Pathol. 2009;174:1985-1992.
34. Ratajczak MZ, Shin DM, Liu R et al. Epiblast/Germ Line Hypothesis of Cancer Development Revisited: Lesson from the Presence of Oct-4+ Cells in Adult Tissues. Stem Cell Rev & Rep. 2010;6:307-316.
35. Guevara-Aguirre J, Balasubramanian P, Guevara-Aguirre M et al. Growth Hormone Receptor Deficiency Is Associated with a Major Reduction in Pro-Aging Signaling, Cancer, and Diabetes in Humans. Science Transl Med. 2011;70:70ra13.
36. Nakagawa N, Chadwick RB, Peltomaki P et al. Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF- -binding sites in colorectal cancer. Proc Natl Acad Sci USA. 2001;98:591-596.
37. Sakatani T, Kaneda A, Iacobuzio-Donahue CA et al. Loss of Imprinting of Igf2 Alters Intestinal Maturation and Tumorigenesis in Mice. Science. 2005;307:1976-1978.
38. Fu VX, Dobosy JR, Desotelle JA et al. Aging and Cancer- -Related Loss of Insulin-like Growth Factor 2 Imprinting in the Mouse and Human Prostate. Cancer Res. 1999;59:3889-3892.
39. Rainier S, Dobry CJ, Feinberg AP. Loss of Imprinting in Hepatoblastoma. Cancer Res. 1995;55:1836-1838.
40. Ratajczak MZ, Kucia M, Jadczyk T et al. Pivotal Role of Paracrine Effects in Stem Cell Therapies in Regenerative Medicine - Can We Translate Stem Cell-Secreted Paracrine Factors and Microvesicles into Better Therapeutic Strategies? Leukemia. 2011 epub doi: 10.1038/leu.2011.389.